-
Erythropoietin Drugs Market valued at US$13.803 billion in 2022, to witness significant growth
20 Feb 2024 14:23 GMT
… developed through biotechnological processes and … pharmaceutical products and medical treatments.
The market analytics report segments the erythropoietin drugs … Pharmaceuticals Ltd.
• FosunPharma
• Rewine Pharmaceuticals
• Kyowa Kirin
• Mircera
…
-
Genexine seeks approval for anemia treatment in Korea
26 Jan 2024 10:38 GMT
Korean biotech firm Genexine announced Friday … Efesa is intended for the treatment and maintenance of anemia induced … Genexine started phase 3 clinical trials for patients with non-dialysis … 39;s third-generation anemia drug Mircera maintained a response rate of …
-
Genexine completes BLA submission for anemia treatment
26 Jan 2024 07:24 GMT
… Drug Safety (MFDS) for Efesa (efepoetin alfa), its anemia treatment … Drug Authority (BPOM) after the successful completion of phase 3 clinical trials … Mircera.
“Based on the phase 3 clinical trial results … domestic biotech company to complete the entire drug …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Hits New 12-Month High at $19.68
12 Jan 2024 15:19 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Reaches New 1-Year High at $19.61
29 Dec 2023 17:03 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Short Interest in Chugai Pharmaceutical Co., Ltd. (OTCMKTS:CHGCY) Declines By 81.1%
14 Dec 2023 18:42 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Sets New 1-Year High at $17.67
02 Dec 2023 13:17 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Sets New 52-Week High at $16.34
18 Nov 2023 15:22 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Chugai Pharmaceutical (OTCMKTS:CHGCY) Posts Quarterly Earnings Results
27 Oct 2023 15:35 GMT
… sale, importation, and exportation of pharmaceuticals in Japan and internationally. The … Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an … analysts' ratings for Chugai Pharmaceutical and related companies with MarketBeat …
-
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
23 Oct 2023 07:50 GMT
… biologics for the treatment of unmet medical needs, together … the 63.2% for Mircera®.
About Efepoetin alfa ( … traded, clinical-stage biotechnology company focused on developing … Pharmaceuticals Division, Consumer Health Division comprising over-the-counter drugs …